|
Open Access Library Journal 11 2024
Impact of COVID-19 on Malaria: Clinical Changes before and during the COVID-19 Pandemic
|
Abstract:
Malaria is a parasitic disease that has always been controlled by national programs worldwide but still remains a public health problem. COVID-19 continues to spread and have an impact on preexisting diseases such as malaria. The management of COVID-19 and the malaria is difficult in low income countries because the two main diseases share the same symptoms and require regular screening. Our study is aimed to evaluate the impact of the COVID-19 pandemic on the epidemiological and clinical profile of malaria in a referral center in Madagascar. It was a retrospective comparative study, the study period was subdivided into two: before COVID-19 1st January to 31st December 2019 and during COVID-19 1st January 2020 to 31st September, 2021 in Infectious Disease department, a reference center for management of malaria and COVID-19. We retained 113 patients including 69 cases before COVID-19 and 44 cases during COVID-19. The statistical tests used for comparison were the parametric chi2 and exact Fischer tests with a significant threshold p ≤ 0.05. Even if the frequency of malaria decreased to 44 (38.94%), severe malaria (n = 44; 42.31%) is the predominant clinical form during COVID-19 period. Furthermore, the mean duration of disease progression to severe malaria was reduced to 2.4 days and the length of stay increased by 8 days. The death rate was broadly similar 17% (n = 12) before COVID-19 versus 16% (n = 7) during COVID-19. The gravity of malaria during COVID-19 may be explained by the disruption of malaria control related to COVID-19 pandemic which highlights that screening and awareness-raising for other diseases such as malaria must be maintained and even reinforced, and included in COVID-19 response.
[1] | Lu, H., Stratton, C.W. and Tang, Y. (2020) Outbreak of Pneumonia of Unknown Etiology in Wuhan, China: The Mystery and the Miracle. Journal of Medical Vi-rology, 92, 401-402. https://doi.org/10.1002/jmv.25678 |
[2] | Osei, et al. (2022) Low Incidence of COVID-19 Case Severity and Mortality in Africa: Could Malaria Co-Infection Provide the Missing Link? BMC Infectious Diseases, 22, Ar-ticle 78. |
[3] | WHO Malaria Profile in Madagascar. https://www.who.int/malaria/publications/country-profiles/profile_mdg_en.pdf?ua=1 |
[4] | Madagascar Covid-19 Da-ta.https://www.google.com/search?q=covid data madagascar |
[5] | Ajayi, I.O., Ajumobi, O.O. and Falade, C. (2020) Malaria and COVID-19: Commonali-ties, Intersections and Implications for Sustaining Malaria Control. The Pan Af-rican Medical Journal. |
[6] | World Health Organization (2013) Management of Severe Malaria: A Practical Handbook. 3rd Edition, World Health Organiza-tion. |
[7] | Weis, D.J., et al. (2020) Indirect Effects of the COVID-19 Pandemic on Malaria Intervention Coverage, Morbidity, and Mortality in Africa: A Geospa-tial Modelling Analysis. The Lancet Infectious Diseases, 21, 59-69. https://doi.org/10.1016/S1473-3099(20)30700-3 |
[8] | WHO (2020) World Malaria Report 2020. World Health Organization. |
[9] | Gavi, S., Tapera, O., Mberikunashe, J. and Kanyangarara, M. (2021) Malaria Incidence and Mortali-ty in Zimbabwe during the COVID-19 Pandemic: Analysis of Routine Surveil-lance Data. Malaria Journal, 20, Article No. 233. https://doi.org/10.1186/s12936-021-03770-7 |
[10] | Hogan, A.B., Jewell, B.L., Sherrard-Smith, E., Vesga, J.F., Watson, O.J., Whittaker, C., et al. (2020) Poten-tial Impact of the COVID-19 Pandemic on HIV, Tuberculosis, and Malaria in Low-Income and Middle-Income Countries: A Modeling Study. The Lancet Glob-al Health, 8, e1132-e1141. https://doi.org/10.1016/S2214-109X(20)30288-6 |
[11] | Nghochuzie, N.N., Olwal, C.O., Udoakang, A.J., Amenga-Etego, L.N. and Amambua-Ngwa, A. (2020) Pausing the Fight against Malaria to Combat the COVID-19 Pandemic in Africa: Is the Future of Malaria Bleak? Frontiers in Microbiology, 11, Article 1476. |
[12] | Wilairatana, P., Masangkay, F.R., Kotepui, K.U., De Jesus Milanez, G. and Kotepui, M. (2021) Prevalence and Characteristics of Malaria among COVID-19 Individuals: A Systematic Review, Meta-Analysis, and Analysis of Case Reports. PLOS Neglected Tropical Diseases, 15, e0009766. https://doi.org/10.1371/journal.pntd.0009766 |
[13] | Mahajan, N.N., Gajbhiye, R.K., Bahirat, S., Lokhande, P.D., Mathe, A., Rathi, S., et al. (2021) Co-Infection of Malariaand Early Clearance of SARS-CoV-2 in Healthcare Workers. Journal of Medical Virology, 93, 2431-2438. https://doi.org/10.1002/jmv.26760 |
[14] | Matangila, J.R., Nyembu, R.K., Telo, G.M., Ngoy, C.D., Sakobo, T.M., Massolo, J.M., et al. (2020) Clinical Characteris-tics of COVID-19 Patients Hospitalized at Clinique Ngaliema, a Public Hospital in Kinshasa, in the Democratic Republic of Congo: A Retrospective Cohort Study. PLOS ONE, 15, e0244272. https://doi.org/10.1371/journal.pone.0244272 |
[15] | Muhammad, Y., Aminu, Y.K., Ahmad, A.E., Iliya, S., Muhd, N., Yahaya, M., et al. (2020) An Elevated 8-Isoprostaglandin F2 Alpha (8-iso-PGF2α) in COVID-19 Subjects Co-Infected with Malaria. The Pan African Medical Journal, 37, 1-10. https://doi.org/10.11604/pamj.2020.37.78.25100 |
[16] | Di Gennaro, F., Ma-rotta, C., Locantore, P., Pizzol, D. and Putoto, G. (2020) Malaria and COVID-19: Common and Different Findings. Tropical Medicine and Infectious Disease, 5, Article 141. https://doi.org/10.3390/tropicalmed5030141 |